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Abstract
Background: For the purpose of diagnosis, psychopathology can be represented as categories of mental disorder, symptom
dimensions or symptom networks. Also, psychopathology can be assessed at different levels of temporal resolution
(monthly episodes, daily fluctuating symptoms, momentary fluctuating mental states). We tested the diagnostic value, in
terms of prediction of treatment needs, of the combination of symptom networks and momentary assessment level.
Method: Fifty-seven patients with a psychotic disorder participated in an ESM study, capturing psychotic experiences,
emotions and circumstances at 10 semi-random moments in the flow of daily life over a period of 6 days. Symptoms were
assessed by interview with the Positive and Negative Syndrome Scale (PANSS); treatment needs were assessed using the
Camberwell Assessment of Need (CAN).
Results: Psychotic symptoms assessed with the PANSS (Clinical Psychotic Symptoms) were strongly associated with
psychotic experiences assessed with ESM (Momentary Psychotic Experiences). However, the degree to which Momentary
Psychotic Experiences manifested as Clinical Psychotic Symptoms was determined by level of momentary negative affect
(higher levels increasing probability of Momentary Psychotic Experiences manifesting as Clinical Psychotic Symptoms),
momentary positive affect (higher levels decreasing probability of Clinical Psychotic Symptoms), greater persistence of
Momentary Psychotic Experiences (persistence predicting increased probability of Clinical Psychotic Symptoms) and
momentary environmental stress associated with events and activities (higher levels increasing probability of Clinical
Psychotic Symptoms). Similarly, the degree to which momentary visual or auditory hallucinations manifested as Clinical
Psychotic Symptoms was strongly contingent on the level of accompanying momentary paranoid delusional ideation.
Momentary Psychotic Experiences were associated with CAN unmet treatment needs, over and above PANSS measures of
psychopathology, similarly moderated by momentary interactions with emotions and context.
Conclusion: The results suggest that psychopathology, represented as an interactome at the momentary level of temporal
resolution, is informative in diagnosing clinical needs, over and above traditional symptom measures.
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Introduction
Nomothetic and Idiographic Components of Diagnosis in
Psychiatry
In the absence of valid biological tests [1], current ICD and
DSM diagnostic manuals define mental disorders on the basis of
operationalized criteria of signs and symptoms, assessed by
clinicians. Multiple algorithmic solutions for combinations of
criteria converge on a single diagnosis of mental disorder, for
example schizophrenia, major depression or bipolar disorder.
Although algorithmic solutions constitute a nomothetic (i.e.
focussing on what patients have in common), and seemingly
objective, system of diagnosis, patients assigned to the same
diagnostic category in practice display high levels of heterogeneity
in psychopathology, treatment needs, course and risk factor
profile. As a result, patient heterogeneity is so extensive that
usefulness and acceptability of DSM and ICD systems remain
limited [2]. A more idiographic (i.e. focussing on what makes a
patient unique) system of diagnosis, taking into account the unique
profile of each individual patient, facilitating personalised clinical
management, may be productive, complementing traditional
nomothetic classification [3].
The need for more idiographic approaches in ICD/DSM
systems is widely recognised, and over the course of the various
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revisions of the diagnostic manuals, attempts have been made to
improve this aspect of diagnosis, particularly by increasing the
number of unique diagnoses, resulting in a proliferation of diagnostic
categories. The ever-growing list of diagnostic categories, however,
does not resolve the problem of extensive within-category
heterogeneity unless, reducing the argument to absurdity, each
individual patient were to have his unique diagnostic category.
The rapid growth in diagnostic labels in DSM and ICD, that
neither delineate valid nosological entities nor define homoge-
neous patient groups, may contribute to the experience of being
labelled, associated with pressure to conform to the stereotype
associated with the label in question [4]. A well-known example is
the practice to describe the variably defined diagnosis of
‘schizophrenia’ as a ‘devastating brain disease’ – or similar
stereotype, in prestigious academic journals [5,6,7,8,9,10], thus
putting pressure on patients to self-stigmatize along stereotypical
lines.
The Three Representations of Psychopathology:
Categories, Dimensions and Interactome
For the purpose of diagnosis, psychopathology can be repre-
sented as categories of mental disorder (groupings based on
clustering of individuals), symptom dimensions (scores on a factor
of clustered symptoms) [11] or symptom networks (symptoms
impacting on each other as part of an interactome) [12]. Instead of
continuously expanding the number of diagnostic categories in
nomothetic systems, an alternative strategy that attempts to truly
combine and balance the need for nomothetic and idiographic
approaches, may produce better results. For example, it has been
proposed that the best ‘mix’ of a nomothetic and idiographic
approach is a limited number of broad diagnostic categories, or
syndromes, for example at the level of the chapters of the DSM
(around 20– anxiety syndrome, depression syndrome, psychotic
syndrome, bipolar syndrome, etc.), whilst at the same time
providing for a personalised, or precision, diagnosis for each patient
within the broad syndrome. The advantage of such a system is that
the diagnostic categories representing the nomothetic system are
kept deliberately broad, suggesting that what patients have in
common can only be found at the level of overarching, broad and
relatively non-specific psychopathology, and that in order to make
a more specific diagnosis, additional patient-specific material
needs to be collected within the broad syndrome.
Initially, the makers of DSM-5 had planned on introducing an
idiographic element alongside the nomothetic system, in the form
of so-called cross-cutting dimensions [13]. Cross-cutting dimensions
were based on the notion that symptoms of mental disorders vary
quantitatively across the different mental disorders, and thus can
be scored cross-diagnostically. For example, experience of
depression is present in most mental disorders, occasioning
cross-diagnostic treatment needs, therefore a single cross-cutting
dimension of depression, scored on a scale ranging from mild to
severe can theoretically be scored across the range of mental
disorders. Similarly, the experience of psychosis is present not only
in psychotic disorders, but also, at subthreshold level, in non-
psychotic disorders, where they markedly impact on course and
treatment response [14,15,16]. Therefore, addition of cross-cutting
dimensions of depression and psychosis in respectively non-mood
and non-psychotic disorders would represent a major improve-
ment, as it would allow clinicians to cross-diagnostically diagnose
treatment-relevant dimensions in disorders of which the criteria
actually exclude the symptoms pertaining to that dimension.
Unfortunately, contrary to the initial plan, cross-cutting dimen-
sions did not find their way into DSM-5.
However, dimensions at the traditional level of temporal
resolution are not necessarily the only or the best measure for a
cross-diagnostic idiographic component of psychopathology. A
recently formulated alternative suggests that psychopathology,
rather than categories or dimensions, may be usefully represented
as a network or interactome. Thus, research indicates that symptoms
are not stable entities that vary together as a function of an
underlying category or even a dimension, but rather form part of a
dynamic system of mutually impacting experiences [12,17,18],
arising from states of early non-specific mental distress which,
depending on the pattern of impact of experiences on each other
over time, may evolve into more recognisable syndromes
[19,20,21,22,23,24].
Level of Temporal Resolution of Psychopathology
Assessment
For the purpose of diagnosis, psychopathology, regardless of
which representation is chosen, can be assessed at different levels
of temporal resolution. Thus, episodes of illness can vary over a
period of months, for example a depressive episode being followed
by a manic episode, or an episode of anxiety being followed by an
episode of psychosis. However, psychopathology can also be
assessed at the level of fluctuating symptoms, varying from day to
day, as assessed for example in the life chart method for patients
with bipolar disorder [25]. Finally, psychopathology can be
assessed at the level of fluctuating mental states that vary from
moment to moment in the flow of daily life, using ambulatory
assessment technology such as the Experience Sampling Method
[26,27,28,29]. Ambulatory assessment represents an important
area of innovation in medicine, and is used for diagnostic
monitoring and treatment evaluation of blood pressure, cardiac
rhythm, brain waves, muscle tone, blood glucose and an
expanding list of other phenotypes. In psychiatry, ambulatory
Figure 1. Experience sampling methodology (ESM) showing
the details of a single day in the ESM paradigm. At 10 random
moments during the day, mental states (eg anxiety, low mood,
paranoia, being happy) and contexts (stress, company, activity, drug
use) are assessed. The arrows represent examples of prospectively
analysing the impact of mental states and contexts on each other over
time, allowing for the construction of an ecological psychopathology
interactome.
doi:10.1371/journal.pone.0086652.g001
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Table 1. Mechanistic findings in Psychiatry with Experience Sampling Method (ESM).
MECHANISM EVIDENCE
MECHANISMS UNDERLYING
TREATMENT RESPONSE AND
PROGNOSIS
In depression, baseline Reward Experience (momentary positive affective response to positive events) and baseline negative
affect variability (variability in momentary negative affective response to negative events) in the ESM paradigm predict outcome,
independent of conventional predictors [62]
In antipsychotics with tight binding to the dopamine D2 receptor, increased levels of estimated D(2) receptor occupancy is
associated with decreased feelings of momentary positive affect (PA) and increased feelings of negative affect (NA) in the ESM
paradigm [63]
In depression, early change in positive rather than negative emotions in the ESM paradigm best predicted response to treatment,
over and above changes in traditional rating scales (eg Hamilton Depression Rating Scale) [64]
In depression, future response to treatment was associated with altered baseline dynamics between NA and PA in the ESM
paradigm: daily life boosts of PA were followed by a stronger suppression of NA over subsequent hours than in other depressed
groups or controls [65]
Remission criteria for schizophrenia are manifested in daily life as fewer instances of momentary aberrant salience, better
momentary mood states and partial recovery of momentary reward experience (positive momentary affective response to
momentary positive events)
Depression treatment with Mindfulness-based Cognitive Therapy is mediated by increased experience of momentary positive
emotions as well as greater appreciation of, and enhanced responsiveness to, pleasant daily-life activities in the ESM paradigm
[66]
Response to antidepressant medication is mediated by increase in Reward Experience (momentary positive affective response to
positive events) rather than reduction in Stress-Sensitivity (momentary negative affective response to negative events) [67]
The therapeutic effect of physical activity on mood is mediated by momentary increases in positive affect rather than reduction in
negative affect in the ESM paradigm [68]
MECHANISMS UNDERLYING
SYMPTOMS
Formation of clinically detectable psychotic symptoms is associated with alterations in the level of momentary transfer of
momentary experience of aberrant salience in the ESM paradigm, in interaction with momentary emotional factors [41]
Onset of psychotic symptoms is mediated in part by the tendency to develop momentary aberrant salience after momentary
increases in negative affect in the ESM daily life paradigm [37]
Paranoid delusionality is driven by momentary negative emotions and reductions in momentary self-esteem in the ESM paradigm
[36], and interactions between genetic liability and momentary stressful events in the flow of daily life [69]
Onset of depressive symptoms is predicted by baseline stress sensitivity (momentary negative affective response to momentary
stressful events) in the ESM paradigm [70]
The construct of negative schizotypy is associated with underlying momentary mental states and ecological interactions in the
ESM paradigm, including decreased momentary positive affect and pleasure in daily life, increased momentary negative affect,
and decreases in momentary social contact and interest [71]
The construct of negative symptoms in schizophrenia does not translate to altered emotional processing in the ESM paradigm:
Lower rather than higher levels of negative symptoms were associated with a pattern of emotional processing in daily life which
was different from healthy controls [72]
MECHANISMS UNDERLYING
ENVIRONMENTAL RISK FACTORS
Exposure to early trauma increases sensitivity to stress in daily life, both in terms of emotional response (momentary negative
affective response to momentary stressful events in daily life) and aberrant salience response (momentary psychotic response to
momentary stressful events in daily life) [52] [73,74]. The pathway from childhood adversity to psychotic symptoms may be
potentiated by genetic liability for depression, impacting on dysfunctional emotional processing of anomalous experiences
associated with childhood trauma [75].
Growing up in an urban environment is not associated with enhanced sensitivity to stress in the flow of daily life [76]
The psychotogenic effects of cannabis are mediated by induction of momentary experiences of aberrant salience in the flow of
daily life [77]
The influence of major Life Events (LE) on onset of psychotic disorder is mediated by the cumulative impact on LE on momentary
stress sensitivity in the ESM paradigm (momentary negative affective response to momentary stress) [78]
MECHANISMS UNDERLYING
GENETIC RISK FACTORS
Genetic effects in depression are mediated by increased momentary negative affective responses to momentary stress in the flow
of daily life [79].
Momentary positive emotions in the ESM paradigm attenuate genetic effects on negative mood bias in daily life [35].
Vulnerability for psychotic disorder is associated, in the ESM paradigm, to both the momentary psychosis-inducing and the
momentary mood-enhancing effects of cannabis [77,80], whilst no differences exist in momentary craving for cannabis [81]
Genetic risk for psychotic disorder is mediated in part by enhanced momentary aberrant salience in response to momentary
stress in the flow of daily life [55], and enhanced momentary negative affective response to stress in daily life [34,82,83]
Familial risk for psychotic disorder is expressed greater level of momentary transfer (or persistence) of experience of aberrant
salience in the flow of daily life [41]
Individuals at genetic risk for depression and psychotic disorder have a different diurnal cortisol profile than those without,
suggesting that altered hypothalamic-pituitary-adrenal axis functioning is an indicator of susceptibility to depression and
psychosis [84,85]
MECHANISMS UNDERLYING
PERSONALITY VARIATION
Borderline patients continually react stronger than patients with psychosis and healthy controls to small disturbances that
continually happen in the natural flow of everyday life. Altered negative affective and aberrant salience stress reactivity may
define borderline personality disorder [86,87]
Psychopathology Interactome Diagnostic Value
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assessment technologies have also been developed in order to
monitor momentary mental states and context in the flow of life,
using the Experience Sampling Method (ESM) [30]. More than in
somatic disorders, ESM in psychiatry is essential to assess context
sensitivity of psychopathology [31], given that symptoms are
embedded in environmental interactions [32] and the function of
the brain is to continually guide adaptive behaviour in response to
environmental change. In the ESM paradigm, individuals are
signalled at random moments in the flow of daily life, and briefly
provide input about emotions, cognitions, behaviours in specific
contexts, including stress, activities and company (Fig. 1) [27,33].
These measures allow for prospective charting of, for example,
negative affect (a dimensional measure composed of several items
indexing negative emotional states), positive affect (similarly a
dimension of items indexing positive emotional states), craving,
paranoia (as an isolated experience), voices (as an isolated
experience), psychosis (as a dimension of correlated items indexing
positive psychotic symptoms) and many other momentary mental
states. Similarly, the course of negative affect can be modelled as a
function of daily life stressors (stress-sensitivity) [34], and positive
affect can be modelled as a function of daily life positive events
(reward) [35]. ESM can help identify how negative affect fuels
paranoia in some individuals [36], and how that in turn may
predict non-clinical psychotic experiences at follow-up [37],
whereas in others paranoia may be driven mainly by changes in
self-esteem when in company with other people [37,38,39,40].
Mental states can also impact on themselves over time. For
example, a mental state of positive affect can transfer from one
moment in the ESM paradigm to the next, indicating the degree of
‘savoring’ of positive affect, impacting mental health outcomes. In
some individuals, savoring occurs more easily than others, under
the influence of, for example, genetic factors, or early trauma [35].
Similarly, momentary persistence of ESM psychosis measures, in
interaction with context and emotional features, predicts patient
status [41].
Explaining the ‘‘WHY’’: Ambulatory Assessment with ESM
can help Identify Mechanisms Underlying Symptom
Formation, Treatment Response and Impact of Genes
and Environment
An extensive body of work employing ambulatory momentary
assessment technology, using ESM, has shown its usefulness for
clinical practice, and its potential for diagnosis in psychiatry [42],
including prediction of personal needs [43]. Experience sampling
measures thus have been shown to underlie and mediate many
clinical and aetiological measures including symptoms, prognosis,
treatment response and genetics (Table 1). While this work only
represents the beginning of the exploration of ambulatory
assessment technology in psychiatry, it suggests that it is well
suited to aid efforts to improve diagnosis and treatment in the area
of mental health. In addition, recent work suggests that patients
who engage in ESM and receive systematic feedback on their
pattern of affective responses to the environment, helping them to
access and alter implicit behavioural and emotional repertoires,
benefit therapeutically, over and above traditional treatments [44].
Thus ESM may be useful for diagnosis (ESM-d), monitoring of
Table 1. Cont.
MECHANISM EVIDENCE
Neuroticism as measured by Eysenck questionnaire may index an environmental risk for decreased daily life levels of PA, and a
genetic as well as an environmental risk for increased NA variability. Decomposing the broad measure of neuroticism into
measurable persons-context interactions increases its ‘informative’ value in explaining psychopathology [88]
PA = positive affect; NA = negative affect.
doi:10.1371/journal.pone.0086652.t001
Figure 2. Prospective development (from top to bottom) of a
cross-diagnostic network of momentary mental states and
contexts making up an ecological psychopathology interac-
tome. Prospective development (from top to bottom) of a cross-
diagnostic network of momentary mental states and contexts making
up the ecological psychopathology interactome; the DSM diagnosis
evolves (from top to bottom) with the dynamics of the network,
showing qualitative changes, as the DSM system assumes that a
‘‘different disease’’ has manifested itself. Thickness of the arrows reflect
the strength of the associations between the elements in the
psychopathology interactome.
doi:10.1371/journal.pone.0086652.g002
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psychopathology in response to treatment (ESM-m) and interven-
tions (ESM-i) [3,18,27,28,42,45].
The Psychopathology Interactome in ESM
Wichers proposed that the representation of psychopathology as
an interactome can be productively studied at the level of
fluctuating momentary mental states, assessed with ESM [18].
Thus, the interacting mental states and contexts assessed in ESM
can be generalised to a full network, the connections of which can
be quantified in terms of their strength and their direction,
whereas the individual mental state and environmental (contex-
tual) elements in the network can be described in terms of the
richness of their connections, functioning as nodes in a network
that can be used to explain, and influence, variation and outcome
of
s-
y-
Figure 3. Hypothesized relationship between Momentary Psychotic Experiences, assessed in the Experience Sampling paradigm, and
Clinical Psychotic Symptoms, measured with the PANSS. The degree to which Momentary Psychotic Experiences (Psy) are manifested as Clinical
Psychotic Symptoms (i.e. their clinical relevance) is determined by interactions between Momentary Psychotic Experiences and momentary negative
affect (NA – higher levels increasing clinical relevance of momentary psychosis), momentary positive affect (PA – higher levels decreasing clinical
relevance of momentary psychosis) and momentary environmental stress (Env – higher levels increasing level of momentary NA and thus increasing
clinical relevance of momentary psychosis). Thickness and colour of arrows indicate respectively strength and direction of association.
doi:10.1371/journal.pone.0086652.g003
Table 2. Degree to which Momentary Psychotic Experiences in the ESM paradigm manifest as Clinical Psychotic Symptoms at PANSS
interview, contingent on momentary context and emotion variables.
Moderating variable
Stratified association Momentary
Psychotic Experiences with Clinical
Psychotic Symptoms (95% CI) P Interaction*
P Interaction* (sensitivity
analysis{)
Momentary negative affect Low NA 0.25 (0.08–0.42) ,0.001 ,0.001
High NA 0.42 (0.25–0.59)
Momentary positive affect Low PA 0.38 (0.21–0.55) 0.002 ,0.001
High PA 0.30 (0.13–0.47)
Momentary event stress Low stress 0.31 (0.14–0.49) 0.008 0.009
High stress 0.39 (0.22–0.57)
Momentary activity stress Low stress 0.30 (0.13–0.47) 0.001 ,0.001
High stress 0.39 (0.22–0.56)
*Interaction tests whether, for example, dichotomous NA moderates the association between Momentary Psychotic Experiences (dependent variable) and Clinical
Psychotic Symptoms (independent variable).
{Sensitivity analysis tests same interaction using dichotomous measure of Momentary Psychotic Experiences (dependent variable) and dichotomous measure of Clinical
Psychotic Symptoms (independent variable).
doi:10.1371/journal.pone.0086652.t002
Psychopathology Interactome Diagnostic Value
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mptoms [18]. It has been shown that the psychopathology
interactome at ESM level is sensitive to staging and profiling of
psychopathology, in that the connections of the interactome
become stronger and more individually profiled with more
advanced stages of psychopathology [24]. An example of how
psychopathology interactome at ESM level may develop over
time, and how this may relate to traditional diagnostic practice, is
given in Fig. 2. Whereas the categorical diagnostic system is prone
to qualitative changes as psychopathology progresses, assuming
that a ‘‘different disease’’ has manifested itself, the ESM
psychopathology interactome gives a rich perspective on qualita-
tive and quantitative changes in the network over time, enabling
patient and clinician to actually understand the ‘microlevel’ [18]
process underlying traditional symptom and diagnostic constructs
of psychopathology (Fig. 2).
Testing Diagnostic Usefulness of the Momentary
Psychopathology Interactome
Given the fact that previous work has demonstrated strong
associations between ESM-level measures of psychopathology and
context on the one hand, and symptoms, risk and treatment
response on the other, and given the fact that prediction of need
for care is the core function of diagnosis in medicine, we wished to
test how well the psychopathology interactome, in the ESM
paradigm, would do in this regard, over and above traditional
symptom criteria of mental disorder. In the current analyses,
therefore, the focus was on demonstrating, in the area of psychosis,
that the clinical and treatment relevance of psychotic symptoms is
determined by momentary interactions between mental states, and
between mental states and context, assessed with ESM.
Thus, it was hypothesized that the experience of psychosis, as
reported in the ESM paradigm by patients, would be associated
with traditional clinical interview measures of psychotic symptoms,
assessed by clinicians using the Positive and Negative Syndrome
Scale (PANSS) [46], but that the strength of the association (i.e. the
Figure 4. Clinical relevance of Momentary Psychotic Experiences (expressed as association with Clinical Psychotic Symptoms) as a
function of momentary ecological and emotional moderators.
doi:10.1371/journal.pone.0086652.g004
Table 3. Degree to which Momentary (Auditory) Hallucinatory Experiences in the ESM paradigm manifest as Clinical Psychotic
Symptoms at PANSS interview, contingent on momentary paranoid ideation.
Level of momentary paranoid ideation
Stratified association Momentary (Auditory)
Hallucinatory Experiences with Clinical Psychotic
Symptoms (95% CI) P interaction*
P Interaction* (sensitivity
analysis{)
Absent 1 0.35 (0.17–0.53) 0.0013 ,0.001
Q 2 0.38 (0.12–0.65)
Q 3 0.57 (0.21–0.93)
Q 4 0.74 (0.31–1.17)
Q 5 0.36 (20.20–0.92)
Q 6 0.02 (20.82–0.85)
Very much 7 1.42 (0.56–2.28)
*Interaction tests whether momentary paranoid ideation moderates the association between Momentary Hallucinatory Experiences (dependent variable) and Clinical
Psychotic Symptoms (independent variable).
{Sensitivity analysis tests same interaction using dichotomous measure of Momentary Hallucinatory Experiences (dependent variable) and dichotomous measure of
Clinical Psychotic Symptoms (independent variable).
doi:10.1371/journal.pone.0086652.t003
Psychopathology Interactome Diagnostic Value
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clinical relevance of the experience of psychosis in the ESM
paradigm) would be dependent on momentary measures of
emotions, context and level of persistence in the psychopathology
interactome in ESM (Fig. 3). Similarly, it was hypothesized that
experience of psychosis, as reported in the ESM paradigm by
patients, would be associated with need for care, assessed with the
Camberwell Assessment of Need (CAN) [47], over and above
PANSS measures of psychotic symptoms, and in interaction with
momentary measures of emotions, context and level of persistence
in the ESM psychopathology interactome.
Methods
The sample consisted of patients with a diagnosis of non-
affective psychotic disorder, who participated at the Maastricht site
of the Dutch national GROUP project [48,49]. In the GROUP
study, patients were identified in selected representative geograph-
ical areas in the Southern part of the Netherlands and Belgium
through a number of representative clinicians whose caseload was
screened for inclusion criteria. Subsequently, a group of patients
presenting consecutively at these services either as out-patients or
in-patients were recruited for the study. Inclusion criteria were (1)
age range 16–50 years, (2) diagnosis of non-affective psychotic
disorder, and (3) good command of the Dutch language. Diagnosis
was based on DSM-IV criteria, assessed with the Comprehensive
Assessment of Symptoms and History interview or Schedules for
Clinical Assessment in Neuropsychiatry (version 2.1). The study
was approved by the standing ethics committee (Medisch Ethische
Toetsingscommissie, UMC Utrecht). Persons identified as potentially
eligible and deemed capable of providing informed consent by
their clinician were given detailed explanation of the study
procedures and were asked for written informed consent for
detailed assessment and for contacting their first-degree family
members (brothers, sisters, parents). Written informed consent was
also obtained from the next of kin, caretakers, or guardians of
those aged 16–17 years. Before written informed consent was
obtained, persons got the opportunity to think about and ask
questions about participation. They could talk about the study
Figure 5. Clinical relevance of Momentary (Auditory) Hallucinatory Experiences (expressed as association with Clinical Psychotic
Symptoms) as a function of momentary paranoid ideation. *expressed as association with Clinical Psychotic Symptoms.
doi:10.1371/journal.pone.0086652.g005
Table 4. Degree to which Momentary (Visual) Hallucinatory Experiences in the ESM paradigm manifest as Clinical Psychotic
Symptoms at PANSS interview, contingent on momentary paranoid ideation.
Level of momentary paranoid ideation
Stratified association Momentary (Visual)
Hallucinatory Experiences with Clinical
Psychotic Symptoms (95% CI) P interaction*
P Interaction* (sensitivity
analysis{)
Absent 1 0.17 (0.06–0.28) ,0.001 ,0.001
Q 2 0.04 (20.13–0.21)
Q 3 0.26 (0.02–0.50)
Q 4 0.32 (0.03–0.61)
Q 5 0.54 (0.15–0.93)
Q 6 0.32 (20.27–0.90)
Very much 7 1.48 (0.88–2.08)
*Interaction tests whether momentary paranoid ideation moderates the association between Momentary Hallucinatory Experiences (dependent variable) and Clinical
Psychotic Symptoms (independent variable).
{Sensitivity analysis tests same interaction using dichotomous measure of Momentary Hallucinatory Experiences (dependent variable) and dichotomous measure of
Clinical Psychotic Symptoms (independent variable).
doi:10.1371/journal.pone.0086652.t004
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with an independent physician who was not involved in the study.
All potential participants who declined to participate or otherwise
did not participate were eligible for treatment (if applicable) and
were not disadvantaged in any way in the case of non-
participation.
Experience Sampling Method (ESM)
Participants received a wristwatch and a set of self-assessment
booklets, one for each day. The wristwatch was programmed to
emit a beep-signal at random moments in each of ten 90-min time
blocks between 7.30 am and 10.30 pm on six consecutive days.
The semi-random beep-design prevents anticipatory behaviour of
participants, and ensures that the full time window between
7.30 am and 10.30 pm is covered for sampling of experience.
After each beep, participants were asked to complete the self-
assessment booklet within 15 minutes, thus collecting reports of
thoughts, current context (activity, social context, location),
appraisals of the current situation and affect. In order to verify
whether the subjects had completed the form within 15 min of the
beep, the time at which subjects indicated they completed the
report was compared to the actual time of the beep (subjects were
not able to check actual beep times retrospectively). All reports
completed more than 15 min after the signal were excluded from
the analysis as earlier work has shown that after this interval,
reports are less reliable and consequently less valid [28]. Subjects
with less than 20 valid reports (out of 60) were similarly excluded
[28]. Earlier work has shown that self-reported compliance,
assessed in a random subset of 58 subjects (1938 observations), was
very high [50].
Measurements
Affect. Adjectives of affect were rated by participants on 7-
point Likert scales ranging from 1= ‘‘not at all’’ to 7= ‘‘very’’.
Following earlier work [34,51], two factor-based scales were
Figure 6. Clinical relevance of Momentary (Visual) Hallucinatory Experiences (expressed as association with Clinical Psychotic Symptoms)
as a function of momentary paranoid ideation. *expressed as association with Clinical Psychotic Symptoms.
doi:10.1371/journal.pone.0086652.g006
Table 5. Degree to which Momentary Psychotic Experiences in the ESM paradigm are associated with Unmet Treatment Needs at
CAN interview, contingent on momentary context and emotion variables, and adjusted for PANSS psychopathology (PANSS
positive, negative and general factors).
Moderating variable
Stratified association Momentary
Psychotic Experiences with CAN Unmet
Treatment Needs (95% CI) P Interaction*
P Interaction* (sensitivity
analysis{)
Momentary negative affect Low NA 0.07 (0.00–0.15) ,0.001 ,0.001
High NA 0.12 (0.05–0.20)
Momentary positive affect Low PA 0.12 (0.05–0.20) ,0.001 ,0.001
High PA 0.07 (0.00–0.15)
Momentary event stress Low stress 0.08 (0.00–0.15) 0.002 0.004
High stress 0.12 (0.04–0.19)
Momentary activity stress Low stress 0.08 (0.01–0.16) 0.002 ,0.001
High stress 0.12 (0.04–0.19)
*Interaction tests whether, for example, dichotomous NA moderates the association between Momentary Psychotic Experiences (dependent variable) and Unmet
Treatment Needs (independent variable).
{Sensitivity analysis tests same interaction using dichotomous measure of Momentary Psychotic Experiences (dependent variable) and dichotomous measure of Unmet
Treatment Needs (independent variable).
doi:10.1371/journal.pone.0086652.t005
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constructed. A ‘‘negative affect’’ (NA) scale was constructed based
on mood adjectives such as ‘‘down’’, ‘‘guilty’’, ‘‘insecure’’, ‘‘lonely’’
and ‘‘anxious’’ (Cronbach’s alpha: 0.82; person-level mean score:
1.8, SD=0.8, range: 1–3.7). A ‘‘positive affect’’ (PA) scale was
constructed based on mood adjectives such as ‘‘cheerful’’,
‘‘relaxed’’ and ‘‘content’’ (Cronbach’s alpha: 0.79; person-level
mean score: 4.5, SD=1.0, range: 1.5–6.8).
Momentary psychotic experiences. A scale representing
momentary anomalous experience was based on the mean score of
eight ESM items on: ‘‘I feel suspicious’’, ‘‘My thoughts are difficult to
express’’, ‘‘I can’t let go of my thoughts’’, ‘‘My thoughts are influenced by other
people’’, ‘‘I feel unreal’’, ‘‘I see things that aren’t really there’’, ‘‘I hear voices’’,
‘‘I am afraid of losing control’’ (Cronbach’s alpha: 0.74; person-level
mean score: 1.5, SD=0.6, range: 1–3.0) in line with earlier work
[52]. The use of these items indicating psychosis has been
validated previously [37,41,52,53,54,55]. This variable is hereafter
also referred to as Momentary Psychotic Experiences.
Persistence of momentary anomalous experience.
Persistence of Momentary Psychotic Experience, in the ESM
framework of consecutive beep moments on a given day, was
defined by calculating the frequency of the ESM-measures of
Momentary Psychotic Experiences, dichotomised around value 1
(absence), persisting from beep moment (t21) to moment (t)
(0 = no persistence; 1 = persistence), the average interval being 90
minutes with range between 15 and 180 minutes.
Event-stress. Consistent with earlier work [52], event stress
was conceptualized as subjective appraised stressfulness of small
daily events. After each beep, subjects rated the most important
recent event on a 7-point Likert scale (23= very unpleasant to
3 = very pleasant). This score was used as an indicator of event-
related stress (recoded 1 to 7, 7 indicating the most unpleasant
event), and is hereafter referred to as Event stress (person-level
mean: 2.6, SD=0.8, range 1–4.4).
Activity-stress. After each beep, people were asked to report
their activity. Then they were asked to judge this activity with
Figure 7. Treatment relevance of Momentary Psychotic Experiences (expressed as association with Unmet Treatment Needs) as a
function of momentary ecological and emotional moderators.
doi:10.1371/journal.pone.0086652.g007
Table 6. Degree to which Momentary (Auditory) Hallucinatory Experiences in the ESM paradigm are associated with Unmet
Treatment Needs at CAN interview, contingent on momentary paranoid ideation, and adjusted for PANSS psychopathology (PANSS
positive, negative and general factors).
Level of momentary paranoid ideation
Stratified association Momentary (Auditory)
Hallucinatory Experiences with CAN Unmet
Treatment Needs (95% CI) P interaction*
P Interaction* (sensitivity
analysis{)
Absent 1 0.04 (20.05–0.14) ,0.001 ,0.001
Q 2 0.09 (20.03–0.21)
Q 3 0.11 (20.04–0.23)
Q 4 0.16 (20.01–0.31)
Q 5 0.35 (0.17–0.53)
Q 6 0.32 (0.03–0.61)
Very much 7 0.85 (0.57–1.12)
*Interaction tests whether momentary paranoid ideation moderates the association between Momentary Hallucinatory Experiences (dependent variable) and Unmet
Treatment Needs (independent variable).
{Sensitivity analysis tests same interaction using dichotomous measure of Momentary Hallucinatory Experiences (dependent variable) and dichotomous measure of
Unmet Treatment Needs (independent variable).
doi:10.1371/journal.pone.0086652.t006
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three subsequent questions on a 7-point Likert scale (1 = not at all
to 7= very): ‘I would rather do something else’, ‘I am not skilled to
do this activity’ and ‘This activity requires effort’. The mean of the
answers to these three questions formed the activity-related stress
scale. To assess the internal consistency of the activity-related
stress scale, a Cronbach’s alpha was calculated (Cronbach’s
alpha= 0.51; person-level mean: 2.4, SD=0.6, range: 1–3.9).
Momentary auditory and visual hallucinations. These
were captured by the ESM items of, respectively, ‘‘I hear voices’’
(person-level mean: 1.4, SD=1.1, range: 1–6.5) and ‘‘I see things
that aren’t really there’’ (person-level mean: 1.2, SD=0.5, range: 1–
3.9). Paranoid delusional ideation was captured using the item ‘‘I
feel suspicious’’ person-level mean: 1.4, SD=0.6, range: 1–3.4).
Clinical psychotic symptoms. The level of positive symp-
toms occurring in the last week was assessed with the Positive and
Negative Syndrome Scale (PANSS) [46]. The score of the positive
symptom subscale in the patients was used as a measure of the
level of positive symptoms (mean: 1.8, SD=0.8, range: 1–3.7).
Other subscales scores used were negative symptoms (mean: 1.5,
SD=0.7, range: 1–4.3) and general psychopathology (mean: 1.6,
SD=0.5, range: 1–3.3).
Treatment needs. Need for care was assessed using the
Camberwell Assessment of Need (CAN) [47]. The CAN includes
22 items (e.g. daytime activities, psychotic symptoms). All CAN
items can be scored 0 (no problem), 1 (there was a problem, but
the problem is met), 2 (unmet need) with a reference period
including the last 3 months. For each individual, a score was
constructed reflecting the total number of unmet needs (mean
score: 2.6, SD=1.9, range: 0–8).
Analyses
All analyses were carried out in Stata12 [56]. ESM data have a
hierarchical structure with multiple observations (level 1) nested
within individuals (level 2) who, in turn, were nested within
families (level 3). Given that hierarchical clustering induces
violation of the assumption of independence of observations,
Figure 8. Treatment relevance of Momentary (Auditory) Hallucinatory Experiences (expressed as association with Unmet Treatment
Needs) as a function of momentary paranoid ideation. *expressed as association with Clinical Psychotic Symptoms.
doi:10.1371/journal.pone.0086652.g008
Table 7. Degree to which Momentary (Visual) Hallucinatory Experiences in the ESM paradigm are associated with Unmet Treatment
Needs at CAN interview, contingent on momentary paranoid ideation, and adjusted for PANSS psychopathology (PANSS positive,
negative and general factors).
Level of momentary paranoid ideation
Stratified association Momentary (Visual)
Hallucinatory Experiences with CAN Unmet
Treatment Needs (95% CI) P interaction*
P Interaction* (sensitivity
analysis{)
Absent 1 0.02 (20.04–0.08) ,0.001 ,0.001
Q 2 0.05 (20.02–0.13)
Q 3 0.04 (20.05–0.13)
Q 4 0.07 (20.04–0.18)
Q 5 0.09 (20.04–0.22)
Q 6 0.27 (0.06–0.48)
Very much 7 0.68 (0.47–0.88)
*Interaction tests whether momentary paranoid ideation moderates the association between Momentary Hallucinatory Experiences (dependent variable) and Unmet
Treatment Needs (independent variable).
{Sensitivity analysis tests interaction using dichotomous measure of Momentary Hallucinatory Experiences (dependent variable) and dichotomous measure of Unmet
Treatment Needs (independent variable).
doi:10.1371/journal.pone.0086652.t007
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standard errors were corrected for hierarchical clustering of
observations within these levels by applying multilevel random
regression models, i.e. statistical models of parameters that vary at
more than one level. Multilevel models are ideally suited for
research designs where the data for participants are organized at
more than one level.
The Stata XTMIXED routine (for continuous Momentary
Psychotic Experiences) and XTMELOGIT routine (for dichotomously
defined Momentary Psychotic Experiences) was used to accommodate
the three levels of hierarchical clustering, yielding non-standard-
ized regression coefficients (XTMIXED) and odds ratios (XTME-
LOGIT). A random slope was added for beep-level independent
variables, which yields more conservative estimates.
Multilevel analyses examined the association between Momentary
Psychotic Experiences (and separately Momentary Hallucinatory
Experiences) as dependent variable and Clinical Psychotic Symptoms
as independent variable, and moderation thereof by emotional
and contextual factors (in the models of Momentary Psychotic
Experiences) and paranoid ideation (in the models of Momentary
Hallucinatory Experiences). This model can be interpreted as the
degree to which Momentary Psychotic Experiences are manifested at a
sufficiently severe level to be recognised as a clinical symptom
during interview, i.e. their clinical relevance, and moderation
thereof by ecological and psychopathological factors. The same
analyses were carried out to examine the association between
Momentary Psychotic Experiences and CAN Unmet Treatment
Needs, adjusted for PANSS positive, negative and general
dimensions of psychopathology. These analyses thus can be
interpreted as examination of the treatment relevance of Momentary
Psychotic Experiences, over and above clinical psychopathology as
measured by the PANSS.
In the models of Momentary Psychotic Experiences as dependent
variable, interactions with ESM-level moderator variables (mo-
mentary NA, PA, event stress and activity stress) were tested with
dichotomous moderator variables, conform previous work in this
area [41]. Thus, scores on momentary NA, PA, event stress and
activity stress were split at the (intra-person) median, creating a
dichotomous indicator of higher or lower than intra-person
average levels of the respective measures. Interactions with
variables measured as ESM beep-level (i.e. multiple measurements
per day within each person such as NA, PA, Event stress, Activity
Stress, Paranoid Ideation) thus reflect intra-individual moderation. In
the case of significant interaction, stratified effect sizes were
calculated by linear combination of the relevant terms in the
model containing the interaction, using the Stata MARGINS
command. The variables making up the interaction terms (i.e.
dichotomous measures of NA, PA, Event Stress and Activity Stress on
the one hand, and dichotomous Clinical Psychotic Symptoms and
dichotomous Unmet Treatment Needs on the other) were not
associated with each other, with the exception of a weak
association between Activity Stress and Clinical Psychotic Symptoms
(OR=1.38, 95% CI: 1.03–1.87).
In the models of Momentary Hallucinatory Experiences (auditory and
visual), moderation was examined with the 7 categories of
momentary paranoid ideation, yielding six interaction terms,
followed by calculation of stratified effects sizes by categories of
scores (1 to 7) of momentary paranoid ideation.
Sensitivity Analysis
Given the skewed distribution of Momentary Psychotic Experiences
and Clinical Psychotic Symptoms, analyses were repeated with
dichotomously defined Momentary Psychotic Experiences (dichotomised
around score .1 as described earlier) on the one hand, and
dichotomously defined Clinical Psychotic Symptoms (dichotomised
around the median split) and Unmet Treatment Needs (dichotomised
around the median split) on the other, and comparing the effects of
the relevant cells in the 262 table occasioned by the combination
of the two dichotomous exposure groups (dichotomous Clinical
Psychotic Symptoms and a binary moderator variable; or dichoto-
mous Unmet Treatment Needs and a binary moderator variable). In
the sensitivity analyses of Momentary Hallucinatory Experiences, visual
and auditory hallucination scores were similarly dichotomised
around value 1 (absence), whereas momentary paranoid ideation
was modelled dichotomously as the intra-person median split.
Results of sensitivity analyses are shown at the level of replication
of P-values of interactions, full results are available upon request.
The effect of Persistence of Momentary Psychotic Experiences was
examined by calculating separately associations between (dichot-
omously defined) Clinical Psychotic Symptoms on the one hand and
both (dichotomously defined) persistent and non-persistent Mo-
mentary Psychotic Experiences, as defined earlier, on the other.
Figure 9. Treatment relevance of Momentary (Visual) Hallucinatory Experiences (expressed as association with Unmet Treatment Needs)
as a function of momentary paranoid ideation. *expressed as association with Clinical Psychotic Symptoms.
doi:10.1371/journal.pone.0086652.g009
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Results
Sample
Six patients were excluded from the analyses as they had filled
in less than 20 ESM-reports, leaving 57 patients with valid data.
Mean age was 28 years (SD=8.1), 40 were men (70%), mean
illness duration was 4.4 years (SD=3.0). Patients had diagnoses of
non-affective psychotic disorder, mostly in the schizophrenia
spectrum (n= 43, 75%).
ESM Measures
The total number of ESM beep-level observations was 2223, or
39 beeps per person. The rate of dichotomous Psychotic Experiences,
over all beeps and all persons (excluding persistent Momentary
Psychotic Experiences), was 25% (364 ESM observations), whereas
the rate of persistent Momentary Psychotic Experiences (excluding non-
persistent Momentary Psychotic Experiences) was 36% (622 ESM
observations). The rate of Momentary Hallucinatory Experiences was
16% (356 ESM observations) and 8% (176 ESM observations) for
auditory and visual hallucinations, respectively.
Clinical Relevance of Momentary Psychotic Experiences:
Associations with Clinical Psychotic Symptoms
Momentary Psychotic Experiences were strongly associated with
Clinical Psychotic Symptoms (continuous: B= 0.35, 95% CI: 0.18–
0.51), also in the sensitivity analysis of dichotomous measures of
the dependent and the independent variable (OR=16.3, 95% CI:
4.2–61.3). Associations were stronger for persistent Momentary
Psychotic Experiences (OR=37.4, 95% CI: 6.1–227.8) than for non-
persistent Momentary Psychotic Experiences (OR=10.4, 95% CI: 3.0–
36.8), although confidence intervals were overlapping, indicating a
statistically inconclusive difference.
Clinical Relevance of Momentary Psychotic Experiences,
and Moderation thereof by Ecological and Emotional
Factors
There was strong evidence (Table 2; Fig. 4) that associations
between Momentary Psychotic Experiences and Clinical Psychotic
Symptoms were moderated by momentary NA (higher levels
increasing probability of Clinical Psychotic Symptoms), momentary
PA (higher levels decreasing probability of Clinical Psychotic
Symptoms), and momentary environmental stress associated with
events and activities (higher levels increasing probability of Clinical
Psychotic Symptoms). Results were similar in the sensitivity analyses
using binary measures of both Momentary Psychotic Experiences and
Clinical Psychotic Symptoms (Table 2).
Clinical Relevance of Momentary Hallucinatory
Experiences, and Moderation thereof by Level of Paranoid
Ideation
There was evidence that associations between Momentary
Hallucinatory Experiences and Clinical Psychotic Symptoms were moder-
ated by level of momentary paranoid ideation both for auditory
hallucinations (Table 3; Fig. 5) and visual hallucinations (Table 4;
Fig. 6). Results were similar in the sensitivity analyses using binary
measures of hallucinatory experiences and paranoid ideation
(Tables 3 and 4).
Treatment Relevance of Momentary Psychotic Experiences:
Associations with Treatment Needs?
Momentary Psychotic Experiences were strongly associated with
Unmet Treatment Needs, both before (B = 0.12, 95% CI: 0.05–0.20)
and after adjustment for the three domains of PANSS psychopa-
thology (positive, negative and general symptoms) (B = 0.10, 95%
CI: 0.03–0.17). In the sensitivity analysis with the dichotomized
measures of the dependent and the independent variable the effect
size was similarly large, although not statistically precise
(OR=4.5, 95% CI: 0.5–38.8).
Expression of Momentary Psychotic Experiences as
Treatment Needs, and Moderation thereof by Ecological
and Emotional Factors
There was strong evidence (Table 5; Fig. 7) that associations
between Momentary Psychotic Experiences and Unmet Treatment Needs,
adjusted for the three domains of PANSS psychopathology, were
moderated by momentary NA (higher levels increasing level of
unmet treatment needs), momentary PA (higher levels decreasing
levels of unmet treatment needs), and momentary environmental
stress associated with events and activities (higher levels increasing
level of unmet treatment needs). Results were similar in the
sensitivity analyses using binary measures of Momentary Psychotic
Experiences (Table 5).
Expression of Momentary Hallucinatory Experiences as
Treatment Needs, and Moderation thereof by Ecological
and Emotional Factors
There was strong evidence that associations between Momentary
Hallucinatory Experiences and Unmet Treatment Needs were moderated
by level of momentary paranoid ideation, in a dose-response
fashion, both for auditory hallucinations (Table 6; Fig. 8) and
visual hallucinations (Table 7; Fig. 9). Results were similar in the
sensitivity analyses using binary measures of hallucinatory
experiences and paranoid ideation (Tables 6 and 7).
Discussion
The findings indicate that momentary mental states, assessed in
patients with psychotic disorders, tap into a core component of
diagnosis – prediction of treatment needs and clinical severity of
psychopathology – contingent on other mental states and
contextual factors, and over and above traditional clinical
measures of symptoms. The findings agree with previous work
suggesting ESM has the potential to serve as a diagnostic system
[42], and that interactions between momentary emotional and
momentary psychotic experiences predict non-clinical psychotic
experiences and patient status [37,41]. Therefore, the results are
compatible with the suggestion that ESM can be used as a cross-
disorder idiographic component of diagnosis, complementing a
limited number of broad syndromes representing the nomothetic
component [3]. Similar to developments in somatic medicine,
ambulatory assessments may be able to personalise the prediction
of treatment needs [28].
An important issue is that the current analyses were based on
between-person comparisons, showing group-level associations
and effect modification thereof, in the momentary psychopathol-
ogy interactome. Outcomes therefore cannot be interpreted at the
level of unique patterns in specific individuals, but rather
demonstrate proof of principle that a psychopathology inter-
actome can have value in the prediction of clinical needs. As
previous work has shown that associations in the interactome
assessed at ESM level show substantial between-person variability
[40], particularly as levels of psychopathology become more severe
[24], the result indicate significant scope for person-specific
idiographic patterns in the interactome. The use of a combination
of group-level and person-specific idiographic patterns of the
psychopathology interactome for the purpose of individual-level
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prediction of care needs, and changes therein, would represent a
significant advance for clinical practice. The best way to further
examine this issue would be to conduct longitudinal studies
assessing psychopathology, care needs and treatment response
over time, in order to assess the contribution and predictive value
of group-level and individual-specific elements of the psychopa-
thology interactome.
With the rapid development of mobile technology, ambulatory
assessment with ESM on mobile phones and other mobile devices
is now feasible, including automatic analysis of ESM data, entered
either as individual items (eg hallucinations or optimism) or
summarised as dimensional measures (eg psychosis or negative
affect), and real time personal feedback on the basis of these
[51,57]. Diagnosis and treatment evaluation based on ambulatory
assessment is collaborative and personalised, providing patients
with possibilities to learn, and to make the implicit explicit, and
thus accessible for change. Diagnosis based on the personal and
cross-diagnostic ESM psychopathology interactome, and change
thereof as a function of treatment and time, in combination with a
limited number of broad syndromes at the level of the chapters of
DSM and ICD (around 20 syndromes) may find a place in mental
health practice. This will enable patients to experience the
diagnostic procedure as collaborative, as the first step in a process
of learning from experience, and reduces the risk of stigmatization
associated with the ‘disorder’ language [58].
Momentary Moderations
While associations between interacting ESM momentary
measures and clinical interview-based symptoms have been shown
in previous work (Table 1), the current analysis is the first to show
that interacting ESM momentary measures are associated with
clinical needs, over and above clinical interview-based symptoms.
In addition, the current analyses for the first time provide
replication for the analyses in epidemiological data that have
shown that clinical relevance of psychotic symptoms is determined
by the degree of co-occurrence of delusions and hallucinations, co-
occurrence being associated with more increased level of exposure
to risk factors, treatment needs, poorer prognosis and greater risk
of clinical transition [59,60,61]. Co-occurrence of hallucinatory
experiences and delusional ideation, at different levels of temporal
resolution, represents a marker of intensification of the psychotic
process, causing buildup from simple to more complex early
psychotic states that increase the risk for help-seeking and, finally,
clinical decompensation. The fact that this process of intensifica-
tion involving the dynamic relationship between delusions and
hallucinations applies to not only the level of temporal resolution
of symptoms in epidemiological studies, but also at the momentary
level of mental state interactions, suggests continuity between the
different level of temporal resolution, and scope for self-assessment
of these dynamic processes in the diagnostic ESM paradigm.
Methodological Issues
An important strength of this study is that it introduces an
element of diagnostic novelty, aiming to investigate the develop-
ment of psychopathology from a novel perspective: exploring the
dynamics between mental states and contexts in individuals with
psychotic psychopathology, in relation to need for care. Gener-
alization of the current findings, however, should be conservative,
since only patients with psychotic disorder were included,
precluding broad generalization across all domains of psychopa-
thology.
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